The human immunodeficiency virus-(HIV) is group of the genus Lentivirus within the family of Retroviridae, subfamily Ortho retrovirinae. Based on genetic characteristics and differences in the viral antigens, HIV is classified into the types 1 and 2 (HIV-1, HIV-2). HIV is identical single -stranded RNA molecule that are enclosed within the core of the virus particle proteins, the genome of the HIV Provirus, also known as DNA, is generated by the Protease against reverse transcriptase RNA genome into DNA, degradation of the RNA and integration of the double -stranded HIV DNA into the human genome. The aim of this study is to determine antigenic peptides from p10, p21, and p51 proteins that can be used for multiple peptide vaccine design using In-Silico study. A total of 73 sequences of three proteins were obtained from NCBI and subjected to multiple sequence alignments using CLUSTALW tool to determine conserved regions.
protease (PR, p12), reverse transcriptase (RT, p51) and RNase H (p15) or RT plus RNase H (together p66) and integrase (IN, p32) . Adjacent to the pol gene, the env reading frame follows from which the two envelope glycoproteins gp120 (surface protein, SU) and gp41 (transmembrane protein, TM) are derived. In addition to the structural proteins, the HIV genome codes for several regulatory proteins: Tat (transactivator protein) and Rev (RNA splicing-regulator) are necessary for the initiation of HIV replication, while the other regulatory proteins Nef (negative regulating factor), Vif (viral infectivity factor), Vpr (virus protein r) and
Vpu (virus protein unique) have an impact on viral replication, virus budding and pathogenesis (5, 6) .HIV-2 codes for Vpx (virus protein x) instead of Vpu, which is partially responsible for the reduced pathogenicity of HIV-2 (7) . The genome structure of the immunodeficiency viruses of chimpanzees (SIVcpand gorillas (SIVgor) is identical to that of HIV-1 (8) .
P10 Retroviral proteases are encoded by a part of the pol gene, for example in that of the human immunodeficiency virus (HIV). The protease gene is located between the gag gene (encoding structural proteins) and other enzymatic genes, such as reverse transcriptase and integrase. There are 93 sequences belonging to the retroviral protease family A2 of the aspartic peptidase clan AA at present, according to the Merops database, which provides information on viral as well as other proteases.
Inhibition of HIV-1 replication in monocyte-derived DCs (MDDCs) is associated with an increased expression of p21, a cell cycle regulator that is involved in the differentiation and maturation of DCs. Induction of p21 in MDDCs decreases the pool of dNTPs and increases the antiviral active.
HIV reverse transcriptase (RT) plays a multifunctional role in the transformation of viral RNA into dsDNA and represents a primary target for treatment of AIDS. Currently, all of the drugs in clinical use target the mature RT p66/p51 heterodimer, however, a single p66 peptide chain functions as the precursor for each subunit of the RT heterodimer, requiring a complex maturation process that includes subunit-selective elimination of a single ribonuclease H (RH) domain.
Based on their genetic make-up, HIV-1 viruses are divided into three groups (eg, M [main] , N, and O group, ). These HIV-1 groups and HIV-2 probably result from distinct cross-species transmission events(9) Pandemic HIV-1 has diversified into at least nine subtypes and many circulating recombinant forms (10, 11) which encode genetic structures from two or more subtypes (eg, A/E=CRF01; A/G=CRF02). The continuously evolving HIV-1 viral diversity poses an immense challenge to the development of any preventive or therapeutic intervention (10) . Infection with two or more genetically distinct viruses could lead to new recombinant viruses.
Recombination takes place at a higher rate than initially predicted,(11) and circulating recombinant forms account for as much as 20% of infections in some regions (eg, southeast Asia).(12)These findings are in agreement with the occurrence of co-infections with multiple distinct isolates in a close temporal context(13,14)Further, superinfections in which time points of virus acquisition are months to years apart have been described, although at a much lower frequency than co-infections(13,15,16) Collectively, these observations challenge the assumption that HIV-1 acquisition happens only once with a singular viral strain and that, thereafter, the infected individual is protected from subsequent infections(17) This lack of immunisation has substantial implications for vaccine development. Emerging evidence suggests that clinical progression to AIDS might be more rapid in individuals with dual infections,(18) and encouraging safer sex practices in viraemic HIV-1-infected people might be appropriate to keep recurrent exposure to new viral strains to a minimum.
According to present knowledge, the spread of HIV started at the beginning of the 20th century Sudan is bordered by countries with high rates of HIV infection. The first AIDS case was reported in 1986, and by 2011 the total number of cases reported had increased to 2218 (26) . In 2002, a behavioral and epidemiological survey (BES) was carried out by Sudan National AIDS Program [9] .
According to the survey, the prevalence among general population was 1.6% (26, 27) . Although this survey was the largest survey conducted in Sudan, it was inconclusive largely due to study limitations and mixing of samples that included both general and at-risk populations (27).
The spread of HIV is influenced by poverty and illiteracy, both of which are widespread in Sudan. Neurological symptoms of peripheral neuropathy or Guillain-Barré syndrome also occurs. (32) The duration of the symptoms varies, but is usually one or two weeks. (32) Due to their nonspecific character, these symptoms are not often recognized as signs of HIV infection. Even cases that do get seen by a family doctor or a hospital are often misdiagnosed as one of the many common infectious diseases with overlapping symptoms. Thus, it is recommended that HIV be considered in people presenting with an unexplained fever who may have risk factors for the infection . (32) The initial symptoms are followed by a stage called clinical latency, asymptomatic HIV, or chronic HIV.(29)Without treatment, this second stage of the natural history of HIV infection can last from about three years (34) to over 20 years (35) on average, about eight years).(36)While typically there are few or no symptoms at first, near the end of this stage many people experience fever, weight loss, gastrointestinal problems and muscle pains. Between 50 and 70% of people also develop persistent generalized lymphadenopathy, characterized by unexplained, non-painful enlargement of more than one group of lymph nodes (other than in the groin) for over three to six months (37) .
Materials and Methods:

In-Silico, Study Materials and Methods
A total of 10 HIV structural poly protein sequences were obtained from NCBI(www.ncbi.nlm.nih.gov/protein/?term=) in FASTA format in Jun 2019 (Table1) For VP10.
Total of 6 HIV structural poly protein sequences were obtained from NCBI (www.ncbi.nlm.nih.gov/protein/?term=) in FASTA format in May 2019 For vp21. , reference sequences were identified from NCBI reference sequence.
Total of 57 reverse transcriptase protein (RT P51) sequences of HIV virus were retrieved from the National Center for Biotechnology Information database (NCBI) (www.ncbi.nlm.nih.gov/protein/?term=) in May 2019, reference sequences were identified from NCBI reference sequence.
All sequences of structural poly protein were subjected to multiple sequence alignments using CLUSTALW tool of BIOEDIT sequence alignment editor (version 7.2.5.0) in order to identify conserved regions between sequences. Then epitopes prediction and analysis of each protein was done using different tools of immune epitope data base IEDB software (http://www.iedb.org). 
Determination of conserve sequence and phylogenic analysis:
The retrieved sequences were aligned by multiple sequence alignment (MSA) using Bio Edit software (version 7.2.5.0) (38) , to obtain the conserved regions. Which were considered candidate epitopes were analyzed by different prediction tools at the Immune Epitope Database IEDB analysis resource (http://www.iedb.org/).
Prediction of B cell epitopes:
Candidate epitopes were analyzed by several B-cell prediction methods which determine the antigenicity, hydrophilicity, flexibility and surface accessibility (39) . The method for predicting B-cell epitopes is the hidden Markov model. The linear predicted epitopes were obtained by using BepiPred linear epitope prediction with a threshold value of -0.165 (40) . The surface accessible epitopes were predicted from the conserved region with a threshold value of 1.000 using the Emini surface accessibility prediction tool (41) . Using the kolaskar antigenicity we determined the antigenic sites with a threshold value of 1.000 (42) .
MHC epitope prediction: MHC class I epitope prediction
MHC I prediction tool has been used to analyze the referential (p10,p21,P51) RT protein of the Artificial neural network (ANN) was chosen as it is perfectly suitable in the incorporated such higher order connections when predicting the binding affinity (43, 44) . Analysis was done using HLA alleles (45) . For all the alleles, peptide length was set to 9 amino acids prior to the prediction. The half maximal inhibitory concentration (IC50) values of the peptide's binding to MHC I molecules was calculated and the ones that had binding affinity (IC50) less than 100 nM were suggested to be promising candidate epitopes.
MHC Class II binding predictions
The referential protein sequence was submitted in the (IEDB) MHC II binding prediction tool (http://tools.immuneepitope.org/mhcii/). For the screening of promising epitopes, human allele reference set (HLA DR, DQ, DP) was used (46, 47) . In MHC II binding analysis at the (IEDB) there are seven prediction methods including IEDB recommended, Consensus, Net MHCII pan, NN-align, SMM-align, combinatorial library and Sturniolo methods. NN-align method was used with a half maximal inhibitory concentration (IC50) 0f 1000 nM. Peptides less or equal to the (IC50) value were proposed to be promising MHC II epitopes (48, 49) .
Population coverage:
The estimation of the population coverage are based on the MHC binding with or without T cell restriction data, there for Nemours based tool was developed to predict population coverage of T cell epitope-based diagnostic and vaccines based on MHC binding with or without T cell restriction data (50) . All alleles that interact with epitopes from P51 RT protein were subjected population coverage tool of IEDB (http://tools.iedb.org/tools/population/iedb_ input) to calculate the whole world population coverage of MHC class I, MHC II and combined MHC I and II alleles for each protein (51).
Homology modeling:-
Raptor X protein structure prediction server available at (http://raptorx.uchicago.edu/Structure Prediction/predict/) was utilized for the creation of the 3D structure and Chimera 1.8 (52) was the tool used to visualize the selected epitopes belonging to the B cell, MHC class I and MHC class II.
Results
Alignment and determination of conserved regions
A total of10 HIV p10,6 of p21,and 57 HIV p51 sequences were obtained from NCBI (www.ncbi.nlm.nih.gov/protein/?term=) in FASTA format in May 2019. , reference sequences were identified from NCBI reference sequence .All sequences of HIVp10,p21 and P51 were subjected to multiple sequence alignments using CLUSTALW tool of BIOEDIT sequence alignment editor in order to identify conserved regions between sequences. Then epitopes prediction and analysis of each protein was done using different tools of immune epitope data base IEDP software (http://www.iedb.org) . 
Prediction of B cell epitopes:
Poly structural protein was tested using Bepipred linear epitope production, Emini surface accessibility and Kolaskar and Tongaonkar antigenicity tool of IEDB. All values equal or greater than the default threshold were considered as potential B-cell binders.
Regarding Emini surface accessibility prediction, the average binding score of poly structural protein was 1.00, and minimum and maximum values as displayed in Table2. All values equal or greater than the default threshold were predicted to have good surface accessibility. All proteins were subjected to Kolaskar and Tongaonkar antigenicity prediction tool of IEDB to predict peptides with probability of being antigenic, the average threshold value for poly structural protein was 1.01. Epitopes with values equal or greater than the average score are considered as antigenic peptides. The result of structural polyprotein showed that three peptides had passed the antigenicity prediction and surface accessibility prediction test, QGYSP from 704 to 708 was found to have greatest score among all other peptides in both tests in p10 and p21,and one peptides had passed the antigenicity prediction and surface accessibility prediction test, FKNL from 346 to 349 was found to have greatest score among all other peptides in both tests in p51. The result is summarized in Table 2 . 
Predictions of T cell Epitopes:-
IEDP server (http://www.iedb.org)was used through specific tools to determine MHC1 and MHC II binding epitopes. This server uses specific scoring IC50 (inhibitory concentration 50) to predict epitopes that bind to different MHC class I and MHC class II alleles.
Prediction of T-cell epitopes and MHC class I interaction analysis
Epitopes sequences of structural poly protein subjected to MHC class I binding prediction tool of IEDP. T-cell epitope predicted to interact with different MHC class I alleles using ANN (artificial natural network) as prediction method and length of nine amino acids.
Using same score for all protein of 100 IC50, The peptide 47 had height affinity to interact with the largest number of alleles for p21.
These 10 sequenced epitopes were obtained from the IEDB MHC I binding epitope prediction tool using ANN method and the reference reverse transcripts protein (p51) as an input. There were 44
human MHC class-I alleles for which the epitopes were predicted the best 3 are 63 "EWEFVNTPP 71 , 70 PPLVKLWYQ 78 and 79 EKEPIVGA 87 . 55 
Prediction of T Helper cell epitopes and interaction with MHC class II
Using MHC class II binding prediction method of IEDB and based on NN align and IC50 of 500 for structural polyprotein. From all predicted epitopes of structural polyprotein that bind to MHC class II, the core sequence 119 IISLWDQSL 127 , 108 CVKLTPLCV 116 bind to(25) alleles. which is largest number of alleles in contrast to other predicted, core sequences in p10. the core sequence 38 YYGVPVWKE 52 , 17 FNMWKNNMV 31 , 20 LLQYWSQEL 34 bind to 43 alleles. which is largest number of alleles in contrast to other predicted, core sequences in p21. the core sequence 7 WKGSPAIFQ 21 that showed affinity for 27 MHC-II molecules, 11 FLWMGYEL 25 that showed affinity for 43 MHC-II molecules ,and 58 WEFVNTPPL 72 that showed affinity for 37 MHC-II molecules . In p51 For MHC class I, five Epitopes with highest population coverage resulted in epitope set of 94.45%.
In MHC class II, five epitopes that interact with class II alleles. resulted in epitope set of 93.6%.for combined population coverage was also calculated for combined MHC class I and class II using proposed epitopes from reserve transcriptase protein which resulted in epitope set of 99.76%. 
Discussion:
In this study we aimed to predict possible peptide vaccine for HIV, regarding epitopes that would elicit an antibody immune response "B-cell epitopes 708 QGYSP from 704 to 708 was found to have greatest score among all other peptides ,and one peptides had got results above thresholds in Bepipred linear epitope prediction, Emini surface accessibility and Kolaskar and Tongaonkar antigenicity prediction methods and have shown 100% conservancy among the (HIV P10,P21) retrieved sequences.
The peptides found in the present study may prove more immunogenic as compared to the earlier reported peptides. Predicted peptides might show the physicochemical instability, to overcome this limitation, several structural as well as physical modification strategies are available to enhance the poor physiochemical stability of peptides. these strategies are including peptidomimetic approach, prodrug approach, analogue formations, hydrophobic ion pairing, conjugation with fatty acids and use of substitute methods of drug administration.
Researchers have been working to gather data linked to HIV to understand its biology, transmission and patho-physiology in order to eliminate the disease completely. In the near future, we anticipate that predicted epitopes have therapeutic potential with an outstanding scope.
In recent studies, novel antigenic epitopes of some essential and vital proteins revealed that can victoriously elicit response of immune system therefore becoming great peptide vaccines targets and protecting host from virus attack. So, the current research was conducted to predict antigenic epitopes of reverse transcriptaseP51 (RT) HIV. We carry out sequence, structure, and conservation analysis as well as homology modeling of reverse transcriptase P51 (RT) of HIV.
Research discloses T and B cell epitopes which are antigenic and conserved among the HIV isolates of different countries. These epitopes are capable to induce a particular immunologic response. Interestingly few of the antigenic epitopes proposed and investigated in this work might present a preliminary set of peptides for future vaccine development against HIV for control and prevention of this devastating epidemic. 
